Evidence map›Paper›PMID 34558860›Full record

ArticleHepatology communications2021

Risk Prediction of Nosocomial and Posthospital Discharge Infections in Alcohol-Associated Hepatitis.

Daniel D Penrice, Serena Shah, Camille A Kezer, Thoetchai Bee Peeraphatdit, Arun J Sanyal, Brian Davis, Kristin C Mara, Vijay H Shah, Patrick S Kamath, Douglas A Simonetto

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Hepatology communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Daniel D Penrice *Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, Rochester, MN, USA.ORCID 0000-0002-9357-9511
Serena Shah *Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, Rochester, MN, USA.
Camille A KezerDepartment of Internal Medicine, Mayo Clinic Rochester, Rochester, MN, USA.
Thoetchai Bee PeeraphatditDivision of Gastroenterology and Hepatology, Mayo Clinic Rochester, Rochester, MN, USA.
Arun J SanyalDivision of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, VA, USA.
Brian DavisDivision of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, VA, USA.ORCID 0000-0002-7567-6748
Kristin C MaraDivision of Biostatistics, Mayo Clinic Rochester, Rochester, MN, USA.
Vijay H ShahDivision of Gastroenterology and Hepatology, Mayo Clinic Rochester, Rochester, MN, USA.ORCID 0000-0001-7620-573X
Patrick S KamathDivision of Gastroenterology and Hepatology, Mayo Clinic Rochester, Rochester, MN, USA.
Douglas A SimonettoDivision of Gastroenterology and Hepatology, Mayo Clinic Rochester, Rochester, MN, USA.
Mayo Clinic · USVirginia Commonwealth University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alcohol-associated hepatitis (AAH) is a severe form of liver injury with mortality as high as 30%-40% at 90 days. As a result of altered immune function in AAH, bacterial infections are common and are associated with poor outcomes. However, determining the risk and subsequent development of infection in patients with AAH remain challenging. We performed a retrospective study of consecutive patients admitted with a diagnosis of AAH at two independent tertiary centers from 1998 to 2018 (test cohort, n = 286) who developed infections following hospitalization. The diagnosis of AAH was confirmed by manual chart review according to the recent National Institute on Alcohol Abuse and Alcoholism definition. Infections were categorized by location and time of diagnosis as hospital-acquired infection (48 hours after admission until discharge) and posthospital infections (up to 6 months following discharge). The cohort was 66% men, and the median age was 48 (21-83) years. Corticosteroids were used in 32% of all patients with AAH. The overall infection rate was 24%. Of those with infections, 46% were hospital acquired and 54% were acquired after hospitalization. Variables found to be significant risk factors for bacterial infection included the presence of ascites on admission (hazard ratio [HR], 2.06), corticosteroid administration (HR, 1.70), Model for End-Stage Liver Disease (MELD) >23 (HR, 2.61), and white blood cell (WBC) count on admission per point (HR, 1.02). Conclusion: In this multicenter cohort study of patients hospitalized with AAH, MELD score, ascites, WBC count, and use of corticosteroids were identified as significant predictors of the development of bacterial infection. We created a novel predictive equation that may be used to aid in the identification of patients with AAH at high risk of infection.

Indexed as

Risk AssessmentAdrenal Cortex HormonesAdultAgedAged, 80 and overAscitesBacterial InfectionsCross InfectionFemaleHepatitis, AlcoholicHospitalizationHumansLeukocyte CountMaleMiddle AgedPatient DischargeAdrenal Cortex Hormones

Identifiers

PMID34558860
PMCPMC8631091
OpenAlexW3183402649

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.